GlobalData on MSN1d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
News Medical on MSN2d
Affordability and supply remain critical to the success of long-lasting HIV drugAffordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...
The new rule was contained within a larger proposal to ensure contraceptive coverage in the face of Republican attacks.
Daily Maverick on MSN2d
Alarming rise in HIV among drug users as government fails to implement policyLess than half of those who tested positive for HIV in Pretoria were aware of their HIV status. As such they would not have ...
With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...
In the complex landscape of chronic health conditions, living with HIV while recovering from a stroke presents a unique set ...
The Dutch Aids foundation Aidsfonds says it is concerned about the rise in cases of HIV in young men who have sex with men.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback